Sorafenib-Induced Bilateral Osteonecrosis of Femoral Heads-Reference-Cited by-同舟云学术

Sorafenib-Induced Bilateral Osteonecrosis of Femoral Heads

Published:2010-01-10 Issue:2 Volume:28 Page:e14-e14
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Guillet Marielle¹,Walter Thomas²,Scoazec Jean-Yves³,Vial Thierry⁴,Lombard-Bohas Catherine¹,Dumortier Jérôme¹

Affiliation:

1. Hospices Civils de Lyon, Hôpital Edouard Herriot, Fédération des Spécialités Digestives, Lyon, France

2. Hospices Civils de Lyon, Hôpital Edouard Herriot, Fédération des Spécialités Digestives, and Université de Lyon, Université Claude Bernard, Lyon, France

3. Université de Lyon, Université Claude Bernard, and Hospices Civils de Lyon, Hôpital Edouard Herriot, Service d'Anatomie et Cytologie Pathologiques, Lyon, France

4. Hospices Civils de Lyon, Centre de Pharmacovigilance, Lyon, France

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2009.23.4252

Reference7 articles.

1. Sorafenib in Advanced Hepatocellular Carcinoma

2. Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors

3. Avascular Necrosis of the Femoral Head: Vascular Hypotheses

4. Is avascular necrosis of the femoral head the result of inhibition of angiogenesis?

5. Vascular complications of selected cancer therapies

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib-Associated Bilateral Osteonecrosis of the Femoral Head;American Journal of Therapeutics;2024-09

2. Exploring the Impact of Novel Anti-Cancer Therapies on Jaw Osteonecrosis and Other Bones: A Comprehensive Review;Journal of Clinical Medicine;2024-03-25

3. Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining;Scientific Reports;2023-07-24

4. Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates;Journal of Endocrinological Investigation;2021-07-21

5. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature;British Dental Journal;2020-06